BioLine Rx

BIOLINERX LTD-SPONS ADR

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

BioLineRx Ltd. - American Depositary Shares

BioLine Rx Ltd

Press Releases

Cognyte Elects Two New Board Members to Strengthen Expertise and Drive Growth

BioLineRx to Report 2024 Annual Results on March 31, 2025

Earnings

BioLineRx Reports 2024 Financial Results and Provides Corporate Update

Small Cap

BioLineRx to Report First Quarter 2025 Results on May 27, 2025

BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update

BioLineRx Announces New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-Line Pancreatic Cancer (PDAC) to be Presented at ASCO 2025 Annual Meeting

News

The CHIPS Act and Peraso Inc. (NASDAQ: PRSO): Advancing Semiconductor Innovation and National Security – More Stocks Inside

BioLineRx to Report Second Quarter 2025 Results on August 14, 2025

BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Penny Stocks

BioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a First-in-Class, Oral, Small Molecule Targeting DNA Damage Response in Glioblastoma and Other Cancers

ALLT

BLRX

BMGL

BSLK

CGEN

CGNT

CSTE

PRSO

SNYR

TIRX

VIVK

Abpro Hldgs

Acurx Pharmaceuticals, Inc. - Common Stock

Acurx Pharmaceuticals

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

BioCardia

Bio Green Med Solution, Inc. - Common Stock

Bio Green Med Solution

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

BioVie

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

enGene Holdings

FibroBiologics

Galecto

iBio

Imunon

Immuron Limited - American Depositary Shares

Immuron

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics

Longeveron

Marker Therapeutics

Minerva Neurosciences, Inc - Common Stock

Minerva Neurosciences

BiomX

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharma

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Soligenix

Sensei Biotherapeutics, Inc. - Common Stock

Comments

BioLine Rx

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO